Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression

FASEB Journal

Volumn 16, Issue 10, 2002, Pages 1151-1162

  Wenger, Roland H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Environmental adaptation; Erythropoietin; Oxygen; Transcriptional regulation; Vascular endothelial growth factor

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; OXYGENASE;

ADAPTATION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HYPOXIA; METABOLISM; MOLECULAR DYNAMICS; OXYGEN SATURATION; PRIORITY JOURNAL; REVIEW;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; DNA-BINDING PROTEINS; GLUCOSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON; LIGASES; MIXED FUNCTION OXYGENASES; NUCLEAR PROTEINS; OXYGEN; RECEPTORS, ARYL HYDROCARBON; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0036320934     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0944rev     Document Type: Review

References (178)

1. Oxygen sensing and molecular adaptation to hypoxia
2. 2 homeostasis by hypoxia-inducible factor 1
3. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
4. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene
5. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia
6. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: Evidence for a widespread oxygen-sensing mechanism
7. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia
8. Purification and characterization of hypoxia-inducible factor 1
9. 2 tension
10. Cloning of a factor required for activity of the Ah (dioxin) receptor
11. The PAS superfamily: Sensors of environmental and developmental signals
12. Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of ARNT and HIF1α
13. An essential role for p300/CBP in the cellular response to hypoxia
14. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
15. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
16. HRF, a putative basic helix-loop-helixPAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels
17. Characterization of a subset of the basic helix-loophelix-PAS superfamily that interacts with components of the dioxin signaling pathway
18. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α
19. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1α
20. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
21. The basic helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors
22. Molecular mechanisms of transcription activation by HLF and HIF1-α in response to hypoxia: Their stabilization and redox signal induced interaction with CBP/p300
23. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygendependent proteolysis
24. The expression and distribution of the hypoxia-inducible factors HIF-1α and H1F-2α in normal human tissues, cancers, and tumor-associated macrophages
25. Perivenous expression of the mRNA of the three hypoxia-inducible factor α-subunits, HIF1α, HIF2α and HIF3α, in rat liver
26. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression
27. aHIF: A natural antisense transcript overexpressed in human renal cancer and during hypoxia
28. A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses
29. A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1α gene
30. Cellular and developmental control of 02 homeostasis by hypoxia-inducible factor 1α
31. HIF-1α is required for solid tumor formation and embryonic vascularization
32. Defective vascularization of HIF-1α-null embryos is not associated with VEGF deficiency but with mesenchymal cell death
33. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
34. Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia
35. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
36. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
37. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling
38. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival
39. Regulation of human placental development by oxygen tension
40. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses
41. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3
42. Physiologically low oxygen concentrations determined in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor β3
43. HIF-1 is expressed in normoxic tissue and displays an organ specific regulation under systemic hypoxia
44. Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain
45. Isoform-specific expression of hypoxia-inducible factor-1α during the late stages of mouse spermiogenesis
46. Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1α in activated T lymphocytes
47. Heat induction of the unphosphorylated form of hypoxia-inducible factor-1α is dependent on heat shock protein-90 activity
48. Early expression of myocardial HIF-1α in response to mechanical stresses: Regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway
49. HIF-1 and human disease: One highly involved factor
50. Mammalian oxygen sensing, signalling and gene regulation
51. 2-regulated prolyl hydroxylation
52. 2 sensing
53. 2-dependent degradation domain via the ubiquitin-proteasome pathway
54. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation
55. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
56. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
57. A conserved family of prolyl-4-hydroxylases that modify HIF
58. Induction of HIF-1α in response to hypoxia is instantaneous
59. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
60. Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1α activation cascade: Implications for HIF-1α gene therapy
61. Efficient translation of mouse hypoxia-inducible factor-1α under normoxic and hypoxic conditions
62. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
63. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit
64. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor α (HIF-α) proteins
65. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
66. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
67. Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein
68. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
69. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein
70. Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
71. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
72. Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
73. Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor
74. Dynamic, site-specific interaction of hypoxia-inducible factor-1α with the von Hippel-Lindau tumor suppressor protein
75. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT
76. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity
77. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
78. Interleukin-1α and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1
79. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts
80. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells
81. A non-hypoxic ROS- sensitive pathway mediates TNF-α-dependent regulation of HIF-1α
82. phox-containing NADPH oxidase
83. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells
84. Normoxic induction of the hypoxia-inducible factor-1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway
85. Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway
86. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: Redox-dependent effect of nitrogen oxides
87. Accumulation of HIF-1α under the influence of nitric oxide
88. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
89. Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways
90. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer
91. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
92. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling
93. iNOS expression inhibits hypoxia-inducible factor-1 activity
94. Nitric oxide affects the production of reactive oxygen species in hepatoma cells: Implications for the process of oxygen sensing
95. Complex role of protein phosphorylation in gene activation by hypoxia
96. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1
97. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1
98. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK
99. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
100. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α
101. Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1α
102. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation - A potential mechanism
103. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
104. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation
105. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
106. Regulation of glutl mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia
107. Loss of PTEN facilitates HIF-1-mediated gene expression
108. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
109. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1
110. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit
111. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like factor
112. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α
113. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis
114. Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells
115. Hypoxia-inducible factor 1α and 1β proteins share common signaling pathways in human prostate cancer cells
116. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): Heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1α
117. Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor
118. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia
119. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells
120. Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor
121. Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells
122. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α
123. ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1α (HIF-1α) and inhibits HIF-1-mediated transcription
124. Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension
125. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein
126. Molecular mechanism of hypoxia-inducible factor 1α-p300 interaction. A leucine-rich interface regulated by a single cysteine
127. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1
128. FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
129. Mouse hypoxia-inducible factor-1α is encoded by two different mRNA isoforms: Expression from a tissue-specific and a housekeeping-type promoter
130. HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1α degradation
131. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression
132. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site
133. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site
134. The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive
135. In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer
136. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements
137. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells
138. The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1
139. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1
140. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
141. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation
142. Identification of a hypoxia response element in the transferrin receptor gene
143. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency
144. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer
145. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
146. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
147. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia
148. Identification of an angiogenic mitogen selective for endocrine gland endothelium
149. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
150. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1
151. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia
152. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand
153. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes
154. 1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle
155. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α
156. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
157. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells
158. Hypoxia-inducible factor-1 (HIF-1) mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKBF3) gene: Its possible role in the Warburg effect
159. Binding and regulation of HIF-1α by a subunit of the proteasome complex, PSMA7
160. Stabilization of wild-type p53 by hypoxia-inducible factor 1α
161. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
162. Jab1 interacts directly with HIF-1α and regulates its stability
163. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
164. Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia
165. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression
166. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3′ enhancer
167. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1
168. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes
169. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes
170. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences
171. Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter
172. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
173. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene
174. Anoxic induction of a sarcoma virus-related VL30 retrotransposon is mediated by a cis-acting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor
175. Hypoxic induction of prolyl 4-hydroxylase α (I) in cultured cells
176. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia
177. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1
178. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia